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IKK Is Required for Prevention of Apoptosis
Mediated by Cell-Bound but Not by Circulating TNF
(PAMPs), IKK activates an alternative NF-B signaling
pathway based on processing of the NF-B2/p100 pre-
cursor protein, which is involved in B cell maturation and
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formation of secondary lymphoid organs (Senftleben et1Laboratory of Gene Regulation
al., 2001).and Signal Transduction
Due to its role in activation of inflammatory responses2 Department of Pharmacology
and suppression of apoptosis, there has been intense3 Center for Molecular Genetics
interest in development of IKK inhibitors for use asSchool of Medicine
antiinflammatory and antineoplastic drugs (Haefner,University of California, San Diego
2002). However, the finding that mice lacking either the9500 Gilman Drive
RelA subunit of NF-B or IKK die during mid-gestationLa Jolla, California 92093
due to TNF-mediated hepatocyte apoptosis (Beg et
al., 1995; Doi et al., 1999; Li et al., 1999a; Li et al., 1999b)
had raised serious concerns about the safety of IKKSummary
inhibitors. For instance, extensive inhibition of NF-B
activation may result in loss of liver function in patientsIB kinase  (IKK) is required for NF-B activation
that experience elevated systemic TNF.and suppression of TNF-mediated liver apoptosis.
The acute or chronic loss of hepatic function, suchTo investigate how IKK suppresses apoptosis, we
as that caused by alcohol, viral infection, or hepatotoxicgenerated hepatocyte-specific Ikk knockout mice,
drugs results in severe pathologies, including fulminantIkkhep, which exhibit little residual NF- B activity but
hepatitis, cirrhosis, and hepatocellular carcinoma (Okuda,are healthy with normal liver function. Unexpectedly,
2000). NF-B is reported to be activated by hepatitis BIkkhep mice are slightly more sensitive than controls
virus (HBV) or HCV infections and alcoholic injury (Liu etto LPS-induced liver apoptosis but are highly suscepti-
al., 2002). Inhibition of NF-B in hepatocytes sensitizesble to liver destruction following concanavalin A
them to apoptosis (Hatano et al., 2001; Xu et al., 1998).(ConA)-induced T cell activation. Unlike LPS, a potent
NF-B activation was also implicated in liver regenera-inducer of circulating TNF, ConA exerts cytotoxic
tion (Cressman et al., 1994; Iimuro et al., 1998), but thiseffects through cell-bound TNF, which activates type
function was recently questioned (Chaisson et al., 2002).1 and 2 TNF receptors (TNFR). While TNFR2 does not
Although partial inhibition of NF-B by degradation re-contribute to NF-B activation, it is important for
sistant IB (IB super-repressor) in hepatocytes doesConA-induced JNK activation, which is augmented by
not compromise normal liver function, it increases sus-the absence of IKK. Using JNK-deficient mice we
ceptibility to apoptosis-inducing stimuli, such as theshow that JNK is required for ConA-induced liver dam-
pan-T cell activator concanavalin A (ConA) and TNFage. Thus, the antiapoptotic function of IKK, which
(Chaisson et al., 2002; Lavon et al., 2000).is most critical in situations that involve cell-bound
TNF functions through two distinct surface recep-TNF, is mediated partially through attenuation of
tors, a 55 kDa receptor (TNFR1), which is the main recep-JNK activity.
tor for processed soluble TNF, and a 75 kDa receptor
(TNFR2), which is the main receptor for biologically ac-Introduction
tive cell-anchored TNF (Grell et al., 1995, 1998). TNFR1,
but not TNFR2, can directly activate the apoptotic path-
NF-B transcription factors are critical regulators of
way through its cytoplasmic death domain (DD), which
genes involved in inflammation, innate immunity, and
recruits TNFR1-associated DD protein (TRADD) and Fas-
suppression of apoptosis (Karin and Lin, 2002). In resting associated DD protein (FADD), to cause caspase-8 acti-
cells, NF-B is retained in the cytoplasm by IB inhibi- vation (Hsu et al., 1996). Through TRADD, which recruits
tors, which are rapidly degraded in response to stimuli, RIP, TRAF2 and TRAF5, TNFR1 engagement also leads
such as tumor necrosis factor  (TNF) and bacterial to IKK and JNK activation (Hsu et al., 1996; Liu et al.,
lipopolysaccharide (LPS), resulting in NF-B nuclear en- 1996). While IKK activation has a clear antiapoptotic
try (Ghosh and Karin, 2002). This process requires phos- function (Karin and Lin, 2002), the role of JNK activation
phorylation of IBs by the IB kinase (IKK) complex, in TNF-induced apoptosis has been enigmatic. Initial
composed of three subunits: IKK, IKK, and IKK (also studies did not reveal either an anti- or a proapoptotic
known as NEMO and IKKAP). Despite structural and role for this effector of TNF signaling (Liu et al., 1996;
biochemical similarities between the IKK and IKK ca- Natoli et al., 1997), but subsequent studies have sug-
talytic subunits (Zandi et al., 1998), they possess distinct gested proapoptotic (De Smaele et al., 2001; Tang et
physiological functions (Chen et al., 2003; Hu et al., 1999; al., 2001) or antiapoptotic functions (Lamb et al., 2003).
Li et al., 1999a, 1999b; Takeda et al., 1999; Tanaka et Even less is known about signaling events associated
al., 1999). Whereas IKK is critical for IB degradation with TNFR2. Although TNFR2 lacks a DD, it has also
and activation of NF-B in response to proinflammatory been associated with the apoptotic response to TNF
stimuli and pathogen associated molecular patterns (Grell et al., 1995). Recent reports suggested that TNFR2
enhances apoptosis by TNFR1 by inhibiting NF-B-
dependent antiapoptotic functions through TRAF2 deg-*Correspondence: karinoffice@ucsd.edu
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radation (Li et al., 2002). By and large, the ability of TNF Ikkhep mice were born at Mendelian frequencies and
exhibited no developmental abnormalities or morbidity.to elicit both antiapoptotic and proapoptotic functions
has been puzzling and the mechanisms that tilt the bal- At 6 weeks of age, the body weights of IkkF/F and Ikkhep
mice, 21.2 g and 20.6 g, respectively, were not signifi-ance in favor of survival or death are of great interest.
The antiapoptotic functions of NF-B in TNF- cantly different. Gross anatomy and histological organi-
zation of the Ikkhep liver were normal, and no spontane-induced apoptosis were recently discussed (Karin and
Lin, 2002). NF-B induces expression of several antiapo- ous liver dysfunction or tumors were observed for at
least 1 year after birth. Furthermore, Ikkhep mice exhibitptotic proteins including cIAPs, c-FLIP, A1, A20, TRAF2,
and Bcl-XL, which block the activity of either death re- normal liver regeneration after partial hepatectomy (data
not shown). IkkF/-:Alb-Cre mice, which exhibit moreceptors or the mitochondrial pathway. Recently it was
suggested that NF-B also functions by attenuating complete Ikk deletion as neonates (Figure 1D), were
also phenotypically normal and did not develop any liverTNF-induced JNK activation (De Smaele et al., 2001;
Tang et al., 2001). However, there is no clear genetic dysfunction (data not shown). Thus, IKK is not required
for postnatal liver development and long-term survivalevidence regarding the physiological mechanism by
which NF-B suppresses TNF-induced apoptosis in under normal husbandry and is not even needed for
liver regeneration.any given cell type.
We sought to examine how IKK suppresses
TNF-induced apoptosis in hepatocytes. In addition, we IKK Is Not Essential for Prevention
wanted to determine whether IKK has any role in liver of LPS-Induced Apoptosis
development, function, or regeneration. We generated Deletion of IKK sensitizes mice to TNF-induced apo-
a liver-specific Ikk knockout mouse strain (Ikkhep), ptosis during mid-gestation (Li et al., 1999a). LPS is one
whose hepatocytes are IKK deficient and defective in of the most potent TNF inducers, but normally LPS or
NF-B activation. Surprisingly, Ikkhep mice are healthy TNF do not cause liver apoptosis unless coadminis-
and fertile with normal postnatal liver development and tered with D-galactosamine (GalN), which blocks tran-
function. Strikingly, Ikkhep mice are not more suscepti- scription in the liver (Bradham et al., 1998; Decker and
ble to LPS-induced hepatitis than normal mice. How- Keppler, 1974). Presumably, GalN prevents induction of
ever, Ikkhep mice are extremely sensitive to ConA antiapoptotic genes. By extrapolation, if IKK is required
administration, exhibiting severe liver failure and apo- for activation of NF-B and the latter is required for
ptosis. We show that the increased proapoptotic effect expression of antiapoptotic genes, Ikkhep mice should
of ConA correlates with its ability to elicit persistent JNK be much more susceptible to LPS-induced fulminant
activation in IKK-deficient hepatocytes. Using JNK- hepatitis than control mice and should not require GalN
deficient mice we demonstrate that prolonged JNK acti- to exhibit extensive liver apoptosis. To examine this
vation, which depends on both TNFR1 and TNFR2, is a point, IkkF/F and Ikkhep mice were administered a high
major contributor to ConA-induced liver damage. These dose (100 mg/kg) of LPS. As expected, IKK activation
and other results suggest that in adult hepatocytes the was reduced in Ikkhep mice, while JNK activation re-
major antiapoptotic function of IKK is to suppress apo- mained unchanged (Figure 2A). Correspondingly, induc-
ptosis caused by activated T lymphocytes that express tion of NF-B DNA binding activity was reduced (Figure
cell bound TNF. This function is exerted through atten- 2B) and so was induction of several NF-B target genes,
uation of JNK activation. such as IL-6 and IL-1, and the antiapoptotic genes, A1
and A20 (Figure 2C). Induction of TNFmRNA, however,
was only slightly reduced in Ikkhep mice and serumResults
TNF levels were similar in both Ikkhep and IkkF/F mice
(Figure 2D).Generation of Hepatocyte-Specific Ikk
Knockout Mice To measure liver damage, we analyzed serum levels
of alanine aminotransferase (ALT) and aspartate amino-IkkF/F mice (Li et al., 2003; Park et al., 2002) were
crossed with Alb-Cre transgenic mice expressing Cre transferase (AST), two liver enzymes, at 8 hr after LPS
injection, and found modest elevation with little differ-recombinase from the hepatocyte-specific albumin pro-
moter (Postic et al., 1999) to generate Ikkhep mice. ences, if any, between IkkF/F and Ikkhep mice (Figure
2E). Thus, unexpectedly, high-dose LPS does not causeCre-mediated recombination was assessed by Southern
blotting of liver genomic DNA. In neonate mice, effi- more liver damage in Ikkhep mice than in control mice.
Indeed, histological analysis revealed only a modestciency of recombination was approximately 35% but
increased to 70%–80% at 6 weeks of age (Figure 1A). increase in the number of apoptotic, TUNEL-positive
hepatocytes in Ikkhep mice 4 hr after LPS challengeThis is consistent with age-dependent increase in DNA
excision in this particular Alb-Cre strain (Postic and (Figure 2F). No TUNEL-positive cells were detected in
untreated mice of either genotype (data not shown).Magnuson, 2000). PCR analysis of genomic DNA indi-
cated that recombination was specific to the liver (Figure Instead of the widespread apoptosis observed in E13
Ikk/ embryos (Li et al., 1999b), the livers of LPS-1B). Western blot analysis of whole liver extract showed
less than 20% of the normal level of IKK in Ikkhep injected Ikkhep mice contained only small foci of ne-
crotic areas with TUNEL-positive cells at 4 hr and almostmice (Figure 1C). Since hepatocytes represent only
70%–80% of total liver mass, residual IKK expression no TUNEL-positive hepatocytes at 24 hr after LPS injec-
tion (see Supplemental Data at http://www.immunity.is most likely due to other cell types. Indeed, no IKK
protein was detected in cultured Ikkhep hepatocytes com/cgi/content/full/19/5/725/DC1). Thus, despite a de-
fective NF-B activation response and normal TNFpro-(Figure 1D).
IKK and TNF-Induced Liver Damage
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Figure 1. Hepatocyte-Specific Deletion of IKK
(A) Southern blot analysis of HindIII-digested genomic DNA isolated from 1 day and 6-week-old mice of the indicated genotypes. F, wt and
 refer to the floxed, wild-type, and deleted alleles, respectively.
(B) PCR analysis of genomic DNA from various organs of an Ikkhep mouse.
(C) Western blot analysis of IKK proteins in livers of IkkF/F and Ikkhep mice.
(D) Western blot analysis of IKK expression in primary hepatocytes derived from 1 day and 6-week-old mice of the indicated genotypes.
duction, induction of liver injury by high-dose LPS was combination with GalN administration does IKK dele-
tion in hepatocytes result in a marked increase in LPS-very limited in Ikkhep mice.
Combined administration of LPSGalN induces fulmi- induced apoptosis.
nant hepatitis dependent on TNF-induced apoptosis
(Nowak et al., 2000). Deletion of IKK in hepatocytes IKK Is Essential for Prevention of T Cell-Driven
Liver Apoptosisresults in higher lethality in mice given LPSGalN (Fig-
ure 3A), suggesting that GalN administration combined Intravenous (i.v.) administration of ConA, which causes
indiscriminate activation of T cells in the liver, is anwith IKK deletion causes a more substantial inhibition
of survival gene expression. Histological analysis (H&E excellent model for acute hepatitis accompanied by
massive hepatocyte apoptosis (Tiegs et al., 1992). Likeand TUNEL staining) revealed extensive apoptosis (more
than 60%) in livers of Ikkhep mice and only mild hepato- LPS-induced hepatitis, ConA-induced liver injury is de-
pendent on TNF (Tiegs et al., 1992; Trautwein et al.,cyte apoptosis (5%–10% of hepatocytes) in surviving
IkkF/F mice challenged with LPS plus GalN (Figure 3B). 1998), which is expressed by NKT cells (Takeda et al.,
2000). ConA administration resulted in IKK-dependentAlthough GalN alone did not cause lethality (data not
shown), it rapidly decreased the abundance of several IKK and NF-B activation in liver (Figure 4A). Interest-
ingly, ConA-induced JNK activity was elevated in Ikkhepantiapoptotic mRNAs (Figure 3C). In summary, only in
Immunity
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Figure 2. Defective NF-B Activation but No Increased LPS Sensitivity in Ikkhep Mice
(A) IKK and JNK activation in livers of Ikkhep, IkkF/F and IkkF/:Alb-Cre mice injected with LPS. At the indicated times, total liver extracts
were prepared and kinase activities measured by immunecomplex kinase assays. Protein recovery was determined by immunobloting.
(B) NF-B activation in livers of LPS-treated IkkF/F and Ikkhep mice. NF-B DNA binding activity was determined by EMSA. Specificity of
binding was determined by competition with “cold” binding site and “supershift” with anti-p65 antibody.
(C) Induction of NF-B target genes in livers at 4 hr after LPS injection. Results shown are averages of three determinations normalized to
the level of cyclophilin mRNA.
(D) Serum TNF levels after LPS administration. Results are averages  S.D. (n 	 4 for each genotype).
(E) Serum levels of liver enzymes at 8 hr after LPS administration. Results are averages  S.D. (n 	 4).
(F) The number of apoptotic hepatocytes at 4 hr after LPS administration was determined by TUNEL staining. Results are averages  S.D.
(n 	 4; the asterisk indicates P 
 0.05 by t test).
mice compared with IkkF/F mice (Figure 4A). As ex- mice (Figure 4B). As seen with LPS, induction of TNF
mRNA (Figure 4B) or circulating TNF protein (Figurepected, induction of NF-B DNA binding activity (data
not shown) and target genes in response to ConA admin- 4C) were not significantly affected. It should be noted,
however, that ConA administration induced at most 10%istration were considerably reduced in livers of Ikkhep
IKK and TNF-Induced Liver Damage
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Figure 3. Ikkhep Mice Are More Sensitive to LPSGalN
(A) Survival curves of IkkF/F (n 	 6) and Ikkhep (n 	 10) mice injected with LPSGalN.
(B) Histological analysis of liver tissue isolated 12 hr after administration of LPSGalN. Tissue sections were analyzed by H&E (upper panels)
or TUNEL (lower panels) staining (X100).
(C) Effect of GalN on liver gene expression. IkkF/F mice were administered GalN and after 0 and 3 hr the livers were removed, hepatocytes
were isolated, and total RNA was extracted. The relative levels of the indicated mRNAs after 3 hr of GalN treatment relative to their level at
the 0 hr time point (given an arbitrary value of 1.0) were determined by real-time PCR. The results represent averages (n 	 4 for each time
point) normalized to the level of cyclophilin mRNA.
as much circulating TNF as induced by LPS (compare by TNFR1 (Chan and Lenardo, 2000; Fotin-Mleczek et
al., 2002; Li et al., 2002). We therefore examined whetherFigure 4C to Figure 2D). Nevertheless, ConA administra-
tion resulted in massive liver injury in Ikkhep mice, re- differential degradation of TRAF2 may correlate with
the different abilities of ConA and LPS to induce livervealed by appearance of circulating liver enzymes (Fig-
ure 4D) and large foci of apoptotic cells (Figure 4E). apoptosis in Ikkhep mice. Administration of ConA re-
sulted in rapid and nearly complete degradation ofHardly any liver injury was observed in similarly treated
IkkF/F mice. TRAF2 in Ikkhep livers within 4 hr (Figure 5C). Only
partial TRAF2 degradation was observed in the IkkF/FUnlike LPS, which mostly causes release of soluble,
circulating TNF, ConA administration results in expres- strain and in both cases TRAF2 levels were restored by
8 hr. Although TRAF2 is thought to be encoded by ansion of cell surface-attached TNF, which is thought to
be the critical mediator of apoptosis in this model (Kus- NF-B target gene (Wang et al., 1998), its basal level
was not reduced in Ikkhep livers. Only a small decreaseters et al., 1997; Solorzano et al., 1997). We confirmed
these findings by staining sections of ConA-and LPS- in TRAF2 abundance was seen following LPS adminis-
tration (Figure 5C).challenged mice with anti-TNF antibodies. Only ConA
challenge resulted in appearance of TNF positive cells
in the liver (Figure 5A). We costained the sections with Analysis of IKK-Deficient Primary Hepatocytes
We next used cultured hepatocytes to examine the ef-anti-CD3 antibody and found that most TNF-
expressing cells were CD3-positive (Figure 5B). We also fect of the IKK deletion on TNF signaling. As de-
scribed above, no IKK protein could be detected inconfirmed that Rag2/ mice, which lack B and T cells,
are completely resistant to ConA-induced liver damage Ikkhep hepatocytes (Figure 6A), whereas in the nonhe-
patocyte fraction of the liver, IKK levels were not differ-(see below).
Cell-bound TNF is thought to be the physiological ent between the two strains (data not shown). Ikkhep
hepatocytes exhibited a marked decrease in TNF-ligand for TNFR2 (Grell et al., 1995). Using tumor cell
lines that overexpress TNFR2, it was shown that engage- induced IKK activity and IB degradation (Figure 6A).
NF-B activation was also markedly reduced. We usedment of TNFR2 can cause degradation of TRAF2 and
thereby enhance the transduction of apoptotic signals RNase protection to examine basal and TNF-induced
Immunity
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Figure 4. Ikkhep Mice Display a Marked Increase in Sensitivity to ConA-Induced Liver Damage
(A) IKK and JNK activation in livers of Ikk F/F and Ikkhep mice injected with ConA (10 mg/kg). Kinase assays and Western blots were performed
as above.
(B) Induction of NF-B target genes in livers at 4 hr after ConA injection was determined by real-time PCR. Results shown are averages of
three separate determinations normalized to the level of cyclophilin mRNA.
(C) Serum TNF levels after ConA administration were determined by ELISA. Values are averages  S.D. (n 	 4 for each genotype).
(D) Serum levels of liver enzymes 8 hr after treatment with ConA. Results shown are averages  S.D. (n 	 8 for each genotype).
(E) Histological analysis of IkkF/F and Ikkhep livers isolated 8 hr after ConA injection. Tissue sections were subjected to H&E (left panels) and
TUNEL (right panels) staining (100).
IKK and TNF-Induced Liver Damage
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Figure 5. ConA Administration Causes Appearance of Cell Bound TNF and TRAF2 Degradation
(A) Induction of cell bound TNF. Mice were given ConA or LPS as above or left untreated and 4 hr later their livers were surgically removed,
fixed (but not permeabilized), and sectioned. The sections were stained with anti-TNF antibody and examined by indirect immunofluores-
cence (600).
(B) CD3-positive cells express TNF. Mice were given ConA and 4 hr after their livers were removed, fixed (but not permeabilized), and
sectioned. The sections were stained with anti-CD3 and anti-TNF antibodies and examined as above (400).
(C) Induction of TRAF2 degradation. Mice were given either ConA or LPS. At the indicated time points livers were removed and total liver
extracts were prepared and analyzed by immunoblotting for TRAF2, using a monoclonal antibody. n.s., nonspecific band used as a loading
control. The results shown include those derived from 3 different Ikkhep mice administered ConA.
expression of putative NF-B target genes. Ikkhep he- Bcl2 and Bak mRNAs, but normal levels of Bcl-XL, Bax,
Fas, and TNFR1 mRNAs.patocytes exhibited markedly reduced levels of TRAIL,
TNF, RANTES, MIP-1, MIP-1, and MCP-1 mRNAs We used cultured hepatocytes to further characterize
the apoptotic response to TNF. To compare the cyto-(Figure 6B). Ikkhep hepatocytes also contained less
Immunity
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Figure 6. Analysis of TNF-Signaling and Apoptosis in Primary Hepatocytes
(A) Defective IKK and NF-B activation by TNF in Ikkhep hepatocytes. Primary hepatocytes were incubated with mouse TNF (10 ng/ml)
and IKK activation was determined as above. Expression of IKK subunits and IB was analyzed by immunoblotting. NF-B activation was
analyzed by EMSA.
(B) Expression of NF-B target genes in primary hepatocytes. Cells were incubated without or with TNF (10 ng/ml) for 4 hr, RNA was extracted
and expression of the indicated genes analyzed by RNase protection.
(C) Induction of NF-B activity by soluble and membrane bound TNF. IkkF/F primary hepatocytes were incubated with a liver membrane
(LM) fraction from ConA-treated Ikkhep mice, containing the equivalent of 300 pg/ml of TNF, as well as the indicated concentrations of
soluble mouse TNF. NF-B activation was analyzed by EMSA.
(D) TNF- or LM-induced cytotoxicity. Primary IkkF/F or Ikkhep hepatocytes were incubated in the absence or presence of the indicated
concentrations of soluble mouse TNF or the LM fraction from ConA-treated Ikkhep mice, containing the equivalent of 300 pg/ml TNF. The
cells were also incubated with a similar amount of LM fraction from LPS-treated Ikkhep, which contained only 80 pg/ml TNF. Cell viability
was measured after 14 hr by trypan blue exclusion. Asterisk indicates P 
 0.05.
(E) Primary IkkF/F and Ikkhep hepatocytes were incubated with 10 ng/ml of soluble mouse (m) TNF as indicated. At the indicated times
(min), cell lysates were prepared and JNK or IKK activity measured by an immunocomplex kinase assay. The levels of JNK and IKK were
examined by Western blotting.
(F) Ikkhep hepatocytes were incubated with 10 ng/ml of either mouse (m) or human (h) TNF and analyzed as above.
IKK and TNF-Induced Liver Damage
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toxic activity of soluble TNF and membrane-bound IKK Inhibits ConA-Induced Apoptosis
by Attenuating JNK ActivationTNF, we isolated a liver membrane fraction (LM), which
contained membrane-bound TNF from ConA-treated The results shown above suggest that TNFR2 is an im-
portant player in ConA-induced apoptosis and persis-Ikkhep mouse liver. Efficient NF-B activation was ob-
served with as little as 300 pg/ml TNF, equivalent to tent JNK activation in IKK-deficient hepatocytes. To
directly test the role of persistent JNK activation inthe LM fraction, but a similar level of NF-B activation
required at least 1 ng/ml soluble TNF (Figure 6C and ConA-induced apoptosis, we used Jnk1 and Jnk2
knockout mice. We found that ConA-induced liver dam-data not shown). We compared the apoptosis-inducing
abilities of the different TNF preparations, as well as age was considerably reduced in both Jnk1/ and
Jnk2/ mice (Figure 7D), which expressed normal levelsthe LM fraction from LPS-treated Ikkhep mice, which
contains much lower amounts of TNF (data not shown). of TNF, TNFR1, and TNFR2 (supplemental data). Simi-
lar results were obtained by direct counting of TUNELWe found that Ikkhep cells were considerably more
sensitive to the LM fraction from ConA-treated mice, positive cells (Figure 7E). We also found that treatment
of Ikkhep cells with a small molecule JNK inhibitorwhile lower levels of cytotoxicity were observed in both
Ikkhep and IkkF/F hepatocytes that were incubated with (SP600125) resulted in inhibition of TNF-induced cell
death, caspase 3 activation, and PARP cleavage (sup-a similar protein amount of the LM fraction from LPS-
treated mice (Figure 6D). We also found that Tnfr1/ plemental data).
hepatocytes were much less sensitive to the LM-fraction
of ConA-treated mice (data not shown), thus confirming Discussion
that much of the cytotoxicity is TNF dependent. Incu-
bation of IkkF/F and Ikkhep hepatocytes with 1 ng/ml The most surprising and important finding of the present
of soluble TNF, an amount sufficient for full NF-B study is that complete ablation of IKK expression in
activation (Figure 6C), did not result in substantial apo- hepatocytes does not result in increased susceptibility
ptosis, whereas incubation with 10 ng/ml soluble TNF to LPS-induced fulminant hepatitis, while it considerably
induced substantial apoptosis only in Ikkhep cells (Fig- increases the sensitivity to ConA-induced liver damage.
ure 6D). Importantly, 10 ng/ml soluble TNF led to sus- LPS is a potent and well-established inducer of TNF,
tained JNK activation in Ikkhep hepatocytes, but only a proinflammatory cytokine with an important role in
transient JNK activation in IkkF/F hepatocytes (Figure chronic viral hepatitis (Gonzalez-Amaro et al., 1994), al-
6E). Similar results were obtained with the LM fraction coholic hepatitis (Bird et al., 1990), and fulminant liver
of ConA-treated mice (see Supplemental Data http:// failure (Muto et al., 1988). However, administration of
www.immunity.com/cgi/content/full/19/5/725/DC1). We either TNF or LPS alone does not lead to liver failure,
also found that human TNF, which activates only except when combined with GalN, a hepatotoxin that
TNFR1, led to more transient JNK activation in Ikkhep blocks transcription in hepatocytes (Bradham et al.,
hepatocytes than mouse TNF, which can activate both 1998; Decker and Keppler, 1974). Not surprisingly, in-
receptors (Figure 6F). duction of liver injury by LPS  GalN is fully dependent
on TNFR1 (Nowak et al., 2000). The exact mechanism
by which GalN sensitizes the liver to LPS or TNF hasA Role of TNFR2 in ConA-
and TNF-Induced Apoptosis not been elucidated, but most likely is due to inhibition
of survival gene transcription. The finding that NF-BOne plausible interpretation of the results shown above
is that membrane-bound TNF activates both TNFR1 activation inhibits TNF-induced apoptosis led to the
expectation that these survival genes are IKK and NF-and TNFR2, while low concentrations (1 ng/ml) of soluble
TNF activate only TNFR1 (Grell et al., 1995). We exam- B dependent (Karin and Lin, 2002; Wang et al., 1998).
Contrary to these expectations, hepatocyte-specific de-ined this interpretation by challenging Tnfr1/ and
Tnfr2/ mice with ConA plus GalN. Indeed, Tnfr1/ and letion of IKK does not result in increased liver injury
upon administration of LPS alone. Thus, inhibition ofTnfr2/ mice exhibited a 90% and 60% reduction in
liver damage, respectively, relative to WT mice (Figure NF-B activity is not sufficient for induction of liver fail-
ure even in the presence of very high levels of circulat-7A). Similar results were obtained through direct count-
ing of TUNEL-positive cells in the livers of these mice ing TNF.
Athough resistant to LPS-induced hepatitis, Ikkhep(data not shown). Rag2/ mice exhibited hardly any liver
damage (Figure 7A). In Tnfr1/ mice, ConA-mediated mice are highly susceptible to ConA-induced hepatitis.
A similar observation was made in mice in which NF-Bliver NF-B activation was totally inhibited, whereas it
remained unchanged in Tnfr2/ mice (Figure 7B). How- was inhibited through hepatocyte-specific expression
of an IB superrepressor (Lavon et al., 2000). ConA-ever, JNK activation was partially reduced in both
Tnfr1/ and Tnfr2/ mice. These results suggest that induced hepatitis is considered to be a good model for
immune-mediated fulminant hepatic failure in humansNF-B activation in hepatocytes is mediated through
TNFR1 and not TNFR2, whereas both TNFR1 and TNFR2 (Gantner et al., 1995; Tiegs et al., 1992). Although ConA
does not trigger release of massive amounts of circulat-contribute to ConA-induced JNK activation and apopto-
sis. Interestingly, the loss of TNFR2 had no effect on ing TNF, its ability to induce hepatitis is TNF depen-
dent (Gantner et al., 1995; Kusters et al., 1996). Hence,LPS-induced JNK activation, which was substantially
reduced in Tnfr1/ mice (supplemental data). Similarly, the differential effect of the IKK deletion on LPS- and
ConA-induced hepatitis is puzzling.TRAF2 degradation, which was induced by ConA plus
GalN, was reduced in both Tnfr1/ and Tnfr2/ mice Our results provide a likely solution for this puzzle by
showing that the role of IKK and NF-B in TNF-(Figure 7C).
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Figure 7. TNFR2 and JNK Are Required for ConA-Induced Liver Apoptosis
(A) Both TNFR1 and TNFR2 participate in ConA-induced liver damage. Mice of the indicated genotypes were injected with ConA (10 mg/kg)
plus GalN (700 mg/kg). After 8 hr, serum levels of ALT were measured. Results shown are averages  S.D. (n 	 4).
(B) TNFR2 is required for maximal JNK activation but is not important for NF-B activation. The indicated mouse strains were injected with
ConA (10 mg/kg) and NF-B DNA binding activity and JNK catalytic activity were measured as above.
(C) TNFR1 and TNFR2 are required for ConA-induced TRAF2 degradation. Mice were treated with ConAGalN as above, the livers were
removed at either 0 or 4 hr after ConAGalN administration, and TRAF2 levels were determined by Western blotting.
(D) JNK1 and JNK2 participate in ConA-induced liver damage. Mice of the indicated genotypes were administered ConA (25 mg/kg) and after
8 hr the serum levels of ALT were measured. Results are averages  S.D. (n 	 3).
(E) Mice of the indicated genotypes were treated with ConA as above. After 8 hr the livers were removed and the extent of apoptosis determined
by TUNEL staining (100).
induced apoptosis depends on how TNF is presented of LPS-treated mice. The strong proapoptotic activity
of cell-bound TNF is most likely due to its ability toto the target cell. In the two forms of liver damage that
are facilitated by inhibition of NF-B, TNF-induced activate both TNFR1 and TNFR2 (Grell et al., 1995). In-
deed, both TNFR1 and TNFR2 are required for inductionapoptosis in mid-gestation and ConA-induced apopto-
sis, TNF is expressed by cells that are present within of liver injury by ConA (Kusters et al., 1997) (Figure 7A),
but only TNFR1 is required for LPS  GalN inducedthe liver and are in close proximity to the hepatocyte
(Doi et al., 1999; Kusters et al., 1997) (Figure 5A). The injury (Nowak et al., 2000). Furthermore, we find that
only high concentrations of TNF (10 ng/ml and above),TNF expressing cells induced by ConA are CD3 posi-
tive and display TNF on their surface. Mice that cannot that surpass the level required for full activation of NF-
B through TNFR1, are capable of inducing selectiveproduce soluble TNF but retain expression of surface
TNF are fully sensitive to ConA-induced hepatitis (Kus- apoptosis of IKK-deficient hepatocytes (Figure 6D).
Using cells engineered to express high levels ofters et al., 1997). It was also shown that cell-bound TNF
is a more potent inducer of apoptosis than soluble TNF TNFR2, engagement of TNFR2 greatly enhances induc-
tion of apoptosis by activated TNFR1, an effect sug-and may be the only form capable of inducing apoptosis
in vivo (Eissner et al., 1995; Grell et al., 1995). In support gested to be mediated through TNFR2-induced TRAF2
downregulation (Chan and Lenardo, 2000; Fotin-Mlec-of these results, we find that the TNF-containing liver
membrane fraction of ConA-treated mice is much more zek et al., 2002; Li et al., 2002). TRAF2 is a signaling
molecule that is recruited to both TNFR1 and TNFR2effective in preferential killing of IKK-deficient hepato-
cytes than soluble TNF or the liver membrane fraction and plays a role in JNK and IKK activation (Liu et al.,
IKK and TNF-Induced Liver Damage
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1996). TRAF2 is also part of an antiapoptotic complex, death. Exactly how NF-B attenuates JNK activation is
induced by NF-B (Wang et al., 1998). When recruited not clear, but our preliminary results are in agreement
to TNFR1, this complex may inhibit caspase 8 activation. with a recent report that increased production of
TRAF2 degradation enhances TNFR1-induced apopto- TNF-induced reactive oxygen species is responsible
sis either by preventing assembly of the antiapoptotic for enhanced JNK activation in NF-B-deficient cells
complex or through attenuation of NF-B activation. (Sakon et al., 2003).
Although our results demonstrating induction of TRAF2 Our findings have several implications of potential
degradation by ConA in Ikkhep mice provide support clinical importance. First, systemic administration of
for this model, it is also possible that enhanced TRAF2 IKK inhibitors, which are currently being developed
degradation is a consequence of more efficient activa- for therapeutic applications in cancer and inflammatory
tion of the apoptotic cascade in IKK-deficient hepato- disease (Haefner, 2002), may not be as hazardous as
cytes. Indeed, we find that ablation of either TNFR2 originally expected, except in the case of liver diseases,
or TNFR1 prevents ConA-induced TRAF2 degradation such as viral and alcoholic hepatitis, where membrane-
(Figure 7C). bound TNF may be present. Such hazards, however,
Another major alteration caused by deletion of IKK may be attenuated by JNK inhibitors. Second, inhibition
pertains to the kinetics and magnitude of JNK activation. of IKKmay be a particularly useful strategy for enhanc-
We find that ConA-challenged, but not LPS-challenged, ing the susceptibility of tumors to attack by infiltrating
Ikkhep mice exhibit more robust and prolonged JNK NKT cells.
activation than similarly treated IkkF/F controls (com-
pare Figure 2A with Figure 4A). Unlike IKK and NF-B Experimental Procedures
activation, which depend mostly on TNFR1, prolonged
AnimalsJNK activation, seen only after ConA challenge (data
C57BL/6 mice (8–10 weeks old) were purchased from The Jacksonnot shown), depends on both TNFR1 and TNFR2 (Figure
Laboratory (Bar Harbor, ME). Mice genetically deficient for TNFR1
7B). Indeed, human TNF, which binds only to mouse (Tnfr1/), TNFR2 (Tnfr2 /), and RAG2 (Rag2/) (all in the C57BL/6
TNFR1 (Tartaglia and Goeddel, 1992), is less capable of genetic background) were also from The Jackson Laboratory. Mice
inducing prolonged JNK activation when compared to deficient in JNK1 (Jnk1/) and JNK2 (Jnk2/) were previously de-
scribed (Chang et al., 2003; Sabapathy et al., 1999) and were back-the same concentration of mouse TNF (Figure 6F).
crossed to C57BL/6 mice for 6 to 7 generations.Most importantly, ablation of either JNK1 or JNK2 results
in marked reduction in ConA-induced liver damage in
Generation of Hepatocyte-Specific Ikk Knockout Micevivo and a small molecule JNK inhibitor can reduce the
IkkF/F mice were generated as described (Park et al., 2002). Alb-
TNF-induced death of IKK-deficient hepatocytes. Cre mice were purchased from the Jackson Laboratory (Postic et
The role of the JNK pathway in TNF-induced apopto- al., 1999). IkkF/F mice, which are aphenotypic, were crossed to Alb-
sis has been a matter of much debate. While initial exper- Cre transgenic mice to eventually generate IkkF/F:Alb-Cre (referred
to as Ikkhep) mice. Genotyping for the Cre transgene was performediments, conducted in tumor cell lines, found no role for
by PCR using the primers: Cre-F, 5-ACCTGAAGATGTTCGCGATJNK in TNF-induced apoptosis (Liu et al., 1996; Natoli
TATCT-3; Cre-R, 5-ACCGTCAGTACGTGAGATATCTT-3. All miceet al., 1997), subsequent experiments using immortal-
were maintained in filter topped cages on autoclaved food and waterized mouse fibroblasts revealed either a proapoptotic
at UCSD animal facilities according to NIH guidelines.
(De Smaele et al., 2001; Tang et al., 2001) or an antiapo-
ptotic (Lamb et al., 2003) role for TNF-induced JNK Liver Injury and Regeneration Models
activation. It was also suggested that one of the mecha- LPS (Escherichia coli O55:B5) (Sigma) was administered i.p. at 100
nisms by which NF-B activation can prevent TNF- mg/kg. Mice were also injected i.p. with 1000 mg/kg GalN (Sigma)
plus 35 g/kg LPS per mouse. ConA (Sigma) was injected i.v. at 10induced apoptosis is by attenuating JNK activation (De
or 25 mg/kg. For partial hepatectomy, mice were anesthetized withSmaele et al., 2001; Tang et al., 2001). These results,
isofluorane and subjected to midventral laparotomy followed byhowever, were questioned by a recent report (Lamb et
removal of the left lateral and median lobes (Higgins and Anderson,al., 2003). Our present results provide clear genetic and
1931). Animals were sacrificed, blood was collected by cardiac
biochemical evidence that one of the primary mecha- puncture, and livers were surgically removed. Serum was separated
nisms by which IKK-dependent NF-B activation and analyzed for transaminase (Sigma) and TNF (R&D systems)
prevents TNF-induced apoptosis in vivo is through at- levels.
tenuation of JNK activation. Nevertheless, our results
Primary Hepatocyte Culturesuggest that this mechanism is only operational under
Hepatocytes were isolated and plated as described (Leffert et al.,conditions where both TNFR1 and TNFR2 are activated,
1979). Cell viability exceeded 90% in all experiments as determinedconditions that are achieved after ConA administration.
by Trypan-blue exclusion. Hepatocytes were cultured for 24 hr inMost likely, the previous controversy regarding the role arginine-free medium containing 10% dialyzed serum to eliminate
of JNK in TNF-induced apoptosis was caused by the other cell types (Leffert et al., 1979).
use of poorly characterized cell culture systems in which
TNFR2 activation or expression are variable. Most likely, Southern and Western Blot Analysis
the switch between TNF-induced survival pathways 10 g of liver genomic DNA was digested with HindIII yielding 3.2
and 1.6 kb fragments for the IkkF and Ikk alleles, respectively.and TNF-induced apoptosis is dependent on the rela-
DNA was separated on agarose gels and transferred to nitrocellu-tive levels of TNFR1 and TNFR2 activation, which modu-
lose. Hybridization was performed using Quik-hyb solution (Stra-late the relative levels of IKK and JNK activities. While
tagene) with 32P-labeled probe (Prime Kit II, Stratagene). Protein
TNFR1 engagement is sufficient for full NF-B activa- lysates were prepared from liver or hepatocytes, separated by SDS-
tion, maximal JNK activity is achieved only when both polyacrylamide gel electrophoresis (PAGE), transferred to Immobi-
TNFR1 and TNFR2 are engaged. Such conditions may lon membranes (Millipore), and analyzed by immunoblotting (Li et
al., 1999b).tilt the balance of the response to TNF in favor of cell
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Immunecomplex Kinase and Electrophoretic Mobility in amplifying p60 TNF-R1 apoptosis signals in T lymphocytes. Eur.
J. Immunol. 30, 652–660.Shift Assays
IKK and JNK immunecomplex kinase assays were performed as Chang, L., Jones, Y., Ellisman, M.H., Goldstein, L.S., and Karin, M.
described, using anti-IKK and anti-JNK1 antibodies (DiDonato et (2003). JNK1 is required for maintenance of neuronal microtubules
al., 1997; Hibi et al., 1993). For gel shift assays, nuclear extracts and controls phosphorylation of microtubule-associated proteins.
were incubated with [32P]dATP-labeled probe containing a B site Dev. Cell 4, 521–523.
(Promega). DNA binding reactions were performed at room tempera-
Chen, L.-W., Egan, L., Li, Z.-W., Greten, F.R., Kagnoff, M.F., and
ture for 30 min in a 10 l mixture consisting of 4% glycerol, 1 mM
Karin, M. (2003). The two faces of IKK and NF-B inhibition: preven-
MgCl2, 0.5 mM EDTA, 0.5 mM dithiothreitol (DTT), 50 mM NaCl, and tion of systemic inflammation but increased local injury following
0.5 g of poly(dI-dC). DNA-protein complexes were separated by
intestinal ischemia-reperfusion. Nat. Med. 9, 575–581.
4% nondenaturing PAGE.
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